期刊文献+

有关血尿素氮评价急性冠脉综合征预后的临床研究 被引量:5

Evaluation of prognosis of acute coronary syndrome by blood urea nitrogen
下载PDF
导出
摘要 目的:探讨血尿素氮(BUN)水平变化对急性冠脉综合征(ACS)预后的影响。方法:选择上海长海医院2000年1月至2005年12月期间住院ACS患者590例,随访4年,了解与患者预后相关的主要不良心血管事件(MACE),如心绞痛、心肌梗死、脑卒中、心衰、死亡等发生情况。按入院时检验的BUN水平分为BUN<20mg/dl组(385例)、BUN20~25mg/dl组(114例)和BUN>25mg/dl(91例),比较不同水平的BUN对ACS预后的影响。结果:与BUN<20mg/dl组及BUN20~25mg/dl组相比,BUN>25mg/dl组心绞痛(50.65%比69.30%比83.75%)、心肌梗死(3.12%比6.14%比21.98%)、心衰(37.40%比50.0%比78.02%)、脑卒中(5.97%比11.40%比25.27%)、死亡(4.41%比8.77%比17.58%)发生率明显升高(P<0.05~0.001)。结论:血尿素氮变化水平与急性冠脉综合征预后相关,随着血尿素氮水平升高,急性冠脉综合征危险性增加,预后越差。 Objective:To investigate the effect of blood urea nitrogen(BUN) evaluating prognosis of acute coronary syndrome(ACS).Methods:A total of 590 ACS inpatients(Jan,2000~ Dec,2005) from Shanghai Changhai hospital were enrolled and followed up for four years.Major adverse cardiovascular events were recorded,including angina pectoris,myocardial infarction,stroke,heart failure and death.According to levels of BUN at admission,the patients were divided into BUN〉20mg/dl group(n=385),BUN 20~25mg/dl group(n=114) and BUN25mg/dl group(n=91).Effects of different levels of BUN on prognosis of ACS were compared and analyzed.Results:Compared with BUN〈20mg/dl group and BUN 20~25mg/dl group,incidence rates of angina pectoris(50.65% vs.69.30% vs.83.75%),myocardial infarction(3.12% vs.6.14% vs.21.98%),heart failure(37.40% vs.50.0% vs.78.02%),stroke(5.97% vs.11.40% vs.25.27%) and death(4.41% vs.8.77% vs.17.58%) significantly increased in BUN〉25mg/dl group,P〈0.05~0.001.Conclusion:Change of level of blood urea nitrogen is significantly correlated with acute coronary syndrome.As level of blood urea nitrogen increases,risk of acute coronary syndrome increases and the prognosis gets worse.
出处 《心血管康复医学杂志》 CAS 2011年第4期345-347,共3页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 血尿素氮 冠状动脉疾病 预后 Blood urea nitrogen Coronary artery disease Prognosis
  • 相关文献

参考文献12

  • 1Heintzen MP, Heidland UE, Strauer BE. Management of pa- tients with acute coronary syndrome: should we rely on cardiac marker [J]?J Interven Cardiol, 2000, 13 (6):447-452.
  • 2Christenson RH, Duh SH, Sanhai W R, et al. Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study [J]. Clin Chem, 2001, 47 (3): 464-470.
  • 3Newby LK, Storrow AB, Gibler WB, et al. Bedside multimark- er testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase MB myoglobin and troponin I (CHECKMATE) study [J]. Circulation, 2001, 103 (14): 1832-1837.
  • 4Azzazy HM, Christenson RH. Cardiac markers of acute coronary syndromes: is there a case for point of-care testing [J]? Clin Biochem, 2002, 35 (1): 13-27.
  • 5Maynard SJ, Menown IBA, Adgey AAJ. Troponin T or tropo- nin I as cardiac markers in ischemie heart disease [J]. Heart, 2000, 83 (4): 371-373.
  • 6Labugger R, Organ L, Collier C, et al. Extensive troponin I and T modification detected in serum from patients with acute myo- cardial infarction [J]. Circulation, 2000, 102 (11): 1221- 1226.
  • 7Chao TH, Li YH, Tsai W C, et al. C reactive protein as a use- ful marker for acute coronary syndromes: manifested with acute chest pain [J]. J Am Coll Cardiol, 2000, 35 (A).:388-396.
  • 8Usberti M, Federico S, Di Minno G, et al. Effects of angioten- sin II on plasma ADH, prostaglandin synthesis, and water excre- tion in normal humans [J], Am J Physiol, 1985, 248 (2 pt 2): F254-259.
  • 9Jernberg T, Lindahl B, James S, et al. Cystatin C: a novel pre dietor of outcome in suspected or confirmed non-ST-elevation a cute coronary syndrome [J]. Circulation, 2004, 110 (16) 2342-2348.
  • 10Rule AD, Larson TS, gergstralh EJ, et al. Using serum creati nine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease [J]. Ann Intern Med, 2004, 141 (12): 929-937.

同被引文献42

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部